objectives To determine the seroprevalence of dengue in central and eastern Sudan and the breadth of neutralising antibody responses.
Introduction
In recent decades, dengue has emerged as a public health problem in tropical and subtropical countries worldwide. Infection with dengue virus (DENV) is mostly asymptomatic or subclinical and persons are usually not aware of previous infection. In approximately 25% of cases, infected individuals develop classical or, more rarely, severe dengue fever. Clinical characteristics of dengue are high fever together with two or more of the following symptoms and signs: headache, pain behind the eyes, muscle and joint pains, nausea, vomiting, swollen lymph nodes and rash [1] . The clinical suspicion of dengue fever can be confirmed by laboratory detection of viral antigen, nucleic acid or anti-DENV IgM in blood serum. In many African countries, laboratory testing for dengue is rarely done because of lacking medical resources. Information about the seroprevalence of dengue helps the clinician in establishing the right diagnosis. If dengue virus infections occur frequently, clinical signs are more likely to indicate the disease. In contrast, clinical suspicion is more frequently wrong if the disease is rare. Similarly, a positive result in a laboratory test for acute DENV infection is more likely to be correct if the disease is frequent.
In Africa, the epidemiology and public health effect of dengue is not clear. Dengue has been reported from most African countries and the vector, Aedes aegypti, is present throughout the continent except for most of the Maghreb states [2] . A recent review of the distribution of dengue in the Middle East and North Africa reported that half of the seroprevalence studies were conducted before 1990 [3] . This shows a need for more studies to examine the burden and epidemiological trends of dengue in Africa.
This study examined the seroprevalence of dengue in Sudan because several recent outbreaks of dengue fever attracted the attention of the health care and public health system. Outbreaks and clinical cases of dengue fever in Sudan have been reported from Port Sudan at the Red Sea in the north-east [4] [5] [6] [7] [8] , Kassala [9] and more recently in the states of Darfur and Kordofan [10] and in Kassala [11] . Few data exist about the seroprevalence of dengue in Sudan. In a study in the Khartoum province with sera from 1988, 49% of the subjects had dengue virus IgG and in a study from the Northern Province 24% had serologic evidence of previous infection with DENV-2 [12, 13] . A report from Lagawa in West Kordofan (between 2005 and 2013: South Kordofan) showed that 27.7% of the sera had IgG antibodies against DENV [14] . In a community-based study in the city of Kassala, 9.4% of sera were positive [15] and in a study with pregnant women admitted to Port Sudan Maternity hospital with fever, 12.8% were DENV IgG-positive [16] (reviewed in 3).
Based on numerous verbal reports of dengue fever that were confirmed by IgM rapid tests or IgM/IgG ELISAs, we hypothesised that dengue virus infection is more frequent in Sudan than previously thought. The aim of this study was to examine the dengue virus seroprevalence in central and eastern Sudan.
Materials and methods

Study sites
Sudan is the third largest country on the African continent. It is located between the tropic of cancer and the eighth parallel north of the equator. Hot and dry desert climate dominates the north, an arid centre with some vegetation surrounds the capital Khartoum and the east, and moderate levels of rain in the summer are typical for the southern part, Kordofan and Darfur. The participants were recruited in Elmawani Hospital in Port Sudan, Red Sea state; Khashm El-Girba Teaching Hospital in Khashm El-Girba, New Halfa Teaching Hospital in New Halfa, a private medical clinic in Kassala city; and El Obeid Teaching Hospital in El Obeid, North Kordofan. Khashm El-Girba, New Halfa and Kassala are in the south of Kassala state at a linear distance of 60-80 km from each other. Thus, we examined participants from five towns in three states. The hospitals are secondary health centres that also provide primary health care for the local community. Port Sudan, Kassala city and El Obeid are cities with more than 400 000 inhabitants. Port Sudan is surrounded by desert without rural areas. Kassala city and El Obeid are surrounded by villages. The vast majority of the patients cared for in the hospitals were presumably from the cities. New Halfa has approximately 80 000 and Khashm el Girba 55 000 inhabitants. The hospitals in these towns also provide primary care for the population in the surrounding villages. The sites were chosen because there was clinical evidence of dengue virus infections.
Serum samples
In December 2012 and January 2013, blood was drawn from 483 consecutive patients in outpatient clinics in five towns in central and eastern Sudan. The participants visited the clinics for medical diagnosis and treatment. Blood samples were collected during the patient's first visit to the doctor. Patients with a temperature above 38°C that were sent to the clinical laboratory for a diagnostic blood drawing were asked to participate in the study. Informed consent was obtained from the participants and, in the case of minors, from their parents. Children in poor general condition were excluded. About 2-3 ml of blood were obtained from consenting patients. Sera were prepared in the hospital laboratories by centrifugation of the clotted blood specimens and kept at À20°C until shipped to Khartoum and later to Leipzig, Germany.
Antibody tests
Sera were examined for IgM antibodies and IgG antibodies using the Panbio Dengue IgM and the Panbio Dengue IgG Indirect ELISA (Alere Inc.). The tests were performed according to the instruction manual with the exception that the IgG tests were done in duplicates. The OD values were normalised with a calibrator specimen contained in the test kits. Measurement values were the Panbio IgG or IgM units. The test units were defined as the ratio of the OD with the test sample and the OD of the calibrator times 10. Values above 11 units were positive, values between 9 and 11 were considered equivocal.
Dengue virus culture and neutralisation test
Dengue virus isolates (DENV-1 (isolate 2522/10), DENV-2 (isolate 3229/11), DENV-3 (isolate 3140/09) and DENV-4 (isolate 3274/0) (provided by J. Schmidt-Chanasit, Bernhard Nocht Institute, Hamburg) were cultured as described in the Appendix S1. A dengue virus microneutralisation assay was used as described previously [17, 18] , and modified for this study. Vero VFM cells (25 000/well) were seeded in 96-well cell culture plates and incubated at 37°C overnight. Serum samples were diluted 1:20 in DMEM/1% FCS and incubated with dengue virus in a cell culture incubator at 37°C for 1 h. Virus-serum dilutions were added onto the cells and the plates were incubated at 37°C. Serum samples were tested in triplicates. The following controls were used: Vero cells without virus, virus diluted with a positive and virus diluted with a negative serum, and a twofold serial dilution of the virus to determine the 50% tissue culture infectious dose (TCID 50 ) used in the test.
The cell culture wells were examined under the microscope for viral cytopathic effect and serum toxicity or microbial contamination. After 8 (DENV-2 to 4) and 13 (DENV-1) days, cell-culture medium was removed. Cells were washed twice with 200ll phosphate-buffered saline (PBS) and fixed with 5% formalin for 20 min. Formalin was removed and the plates were dried in the air. The plates were stained by an ELISA technique. Firstly, the plates were washed with water and the wells were blocked for 20 min with PBS containing 3% bovine serum albumin. The blocking solution was discarded and the cells were permeabilised with 100-ll staining/permeabilisation solution (0.5% saponin in PBS) for 20 min. The solution was discarded and the mAb 4G2 (2 lg/ml, hybridoma HB-112, ATCC) was added in staining/permeabilization solution for 1 h. The antibody solution was discarded and the plates were washed four times with deionised water and PBS containing 0.1% Tween-20 (PBS-T). Rabbit-anti-mouse IgG/HRP antibody (1:1000, DAKO, product no. P0260) in staining solution was added to the wells and incubated for 1 h. The plates were washed five times with water and PBS-T and TMB substrate (TMB Soluble Reagent, TM4500, ScyTek Laboratories, Inc.) was added for 5-30 min. The enzymatic reaction was stopped with 1 N H 2 SO 4 . All incubations were made at room temperature. The plates were read with a photometer at a wavelength of 450 nm and a reference wavelength of 570 nm. The TCID 50 of the viral input was calculated using the Spearman-K€ arber equation (Appendix S1). Tests were valid when the viral titre was between 8 and 32 TCID 50 /sample. The mean of the OD in control wells of Vero cells without virus plus 3 standard deviations was considered as the cut-off for infection. OD values above the cut-off indicated infection and lack of neutralisation. Serum samples were considered neutralising antibody (nAb)-positive when two or three culture replicates inhibited DENV infection to background absorbance values. Results were equivocal if a single well had OD values <50% of the non-neutralising serum control, and the test was negative for nAb when viral infection was not inhibited in any of the culture wells. We validated the microneutralisation test regarding cross-reactivity with antibodies against yellow fever virus with sera obtained 3 weeks after yellow fever vaccination. There was no cross-reaction indicating that the test is specific with respect to immune responses against yellow fever virus (data not shown).
Quantitative analysis of dengue IgG levels
The Panbio dengue IgG ELISA produces quantitative results in the form of Panbio units (PBU). To examine whether the frequency of infection in a particular area affects the level of dengue-specific IgG in the affected inhabitants, we compared the seroprevalence and the level of dengue-specific IgG in the three states. IgG Panbio unit values were compared with a two-tailed MannWhitney U test (www.socscistatistics.com). The null hypothesis was discarded and differences were considered significant if P was <0.05.
Results
Study subjects and sample characteristics
Study subjects were selected in hospitals in Port Sudan, Red Sea state; in Khashm el-Girba, New Halfa and Kassala city in Kassala state; and in El Obeid, North Kordofan. Sera were collected in December 2012 and January 2013 from patients with fever above 38°C. The age of the participants ranged from 1 to 91 years; median age was 40.7 years and similar in males (41.0 years) and females (40.3 years). Females (57.3%) slightly outnumbered males. The vast majority of subjects were adults; only 55 (11.3%) were children and adolescents under 18 years (Table 1) .
Dengue virus seroprevalence
The sera were grouped into classes of previous infection, no previous infection, indeterminate previous infection and late acute or recent infection according to the serological results. Three hundred and two of the 483 serum samples were IgM-negative and IgG-positive indicating previous infection. One hundred and thirty were IgGnegative indicating that the donors had not previously been infected with dengue virus or antibody levels below the detection limit. This group contains both IgM-positive and IgM-negative sera. Seventeen sera were IgMnegative and IgG equivocal and were indeterminate in terms of previous DENV infection. Thirty-four sera were DENV IgM-positive or equivocal and IgG-positive or equivocal indicating late acute or recent DENV infection ( Table 2) .
The 34 sera from participants with late acute or recent dengue infections were excluded from seroepidemiological analysis. The 302 dengue IgG-positive IgM-negative sera amount to 67.3% of the remaining 449 sera. Serological signs of previous DENV infections were most frequent in Port Sudan (106 of 119 sera, 89.1%). The proportion of seropositives was lower in Kassala state (128 of 210 sera, 61.0%), and in El Obeid, North Kordofan (68 of 120 sera, 56.7%) (Figure 1a) . The percentage of subjects with previous DENV infection varied with age. In Port Sudan, the seroprevalence was 67% in children and adolescents aged 9-17 years. It was 90% in adults aged 18-50 years and 97% in the age group over 50. In Kassala state, 40% of adolescents, 61% of the young and middle-aged adults and 74% of subjects above 50 years had previously had DENV infections. The situation was different in El Obeid: there the percentage of subjects with previous DENV infection did not increase with age. Sixty per cent of children and young people aged 9-17 years, 55% of adults aged 18-50 and 50% of participants older than 50 were DENV IgG-seropositive (Figure 1b) .
Specificity of the dengue IgG ELISA and breadth of the neutralising antibody responses
To examine the specificity of the ELISA results, DENV neutralisation tests were performed. Thirty-two sera were randomly selected. Thirty-one of these neutralised dengue viruses. Twelve sera from Port Sudan, 6 of 13 sera from Kassala state and 2 of 7 sera from El Obeid neutralised all four dengue viruses. Most of the other sera neutralised two or three DENV serotypes. Sera from El Obeid neutralised DENV-1, -3 and -4 slightly more frequently than DENV-2 (Table 3) .
Dengue IgG levels
Repeated antigen contact through natural exposure and vaccination boosts the immune response. To examine if the degree of exposure to dengue virus infections in a community affects the dengue virus-specific antibody level in the population, we compared the dengue virus-specific antibody levels of the sera from Port Sudan (N = 106), Kassala state (N = 128) and from El Obeid (N = 68). Significantly higher dengue IgG values were obtained with sera from Port Sudan than with samples from Kassala and El Obeid. The dengue IgG levels in sera from Kassala and El Obeid were comparable (Figure 2 ).
Discussion
The study examined dengue IgG in patients with fever in outpatient clinics in Sudan with the aim of extrapolating from the sample a picture of the dengue immune status in the general population. Serum sampling from patients without serologic (IgM) evidence of acute DENV infection was considered a suitable substitute for the general population. Two-thirds of the sera were IgG-positive. The seroprevalence was highest in Port Sudan in Red Sea state, where almost all individuals over 50 had evidence of previous DENV infection. DENV infections in Red Sea state also occurred at an earlier age than in Kassala and North Kordofan. 67% of sera from subjects under 18 from Port Sudan had antibodies against DENV indicating that first infections are usually acquired in childhood and adolescence. These findings show that DENV infections are widespread in Sudan and affect Port Sudan, Kassala and North Kordofan to a different degree.
The seroprevalence in the El Obeid Teaching Hospital did not increase with age. In that hospital, younger age groups had higher frequencies of DENV infection. A possible explanation is a blood sampling bias. Participants were selected irrespective of their place of original residence. In 2011, hundreds of displaced persons, mostly women and children from South Kordofan, came to El Obeid for shelter [19] . It is possible that a disproportionally large fraction of sera in the young age group was from this group of individuals. The refugees may have had a higher susceptibility to DENV infection due to the circumstances of displacement or they may come from areas in which DENV infections are hyperendemic.
The DENV IgG concentration in the sera from Port Sudan was significantly higher than in the other towns indicating an association between the dengue seroprevalence and virus-specific antibody levels. As secondary DENV infections boost the immune response, the vigorous dengue IgG response in Port Sudan could reflect recent DENV infections in a substantial fraction of the participants [20] .
DENV antibody tests are notorious for cross-reactions with sera from individuals that have been infected with other flaviviruses [21] [22] [23] . To validate the ELISA data, we performed neutralisation tests with a subgroup of the sera. The tests showed that the ELISA was highly specific. Approximately 96.8% of the IgG ELISA-positive serum samples contained DENV-neutralising antibodies. This is similar to the results of a recent study in Malaysia where the Panbio IgG Indirect ELISA had a specificity of 100% compared with a neutralisation test [24] .
The high seroprevalence in Port Sudan indicates an almost universal exposure to dengue viruses. The seroprevalence in this town was comparable to that in the South Indian state Tamil Nadu [25] and in several countries in Southeast Asia [24, 26] . The seroprevalence was higher than in other countries in Africa and in the Middle East [3, 27] . The seroprevalence data were also higher than what was previously reported from Sudan. Previous studies from Port Sudan, Kassala, West Kordofan and the Northern Province found DENV IgG in 9-49% of the tested sera [12, 13, 15, 16, 28] (reviewed in [3] . Together the seroprevalence data indicate that further seroepidemiologic testing and surveillance are needed in Sudan.
WHO recommends an integrated vector management for mosquito control to prevent transmission of vectorborne diseases including dengue fever [29] . The Federal Ministry of Health of Sudan has instituted several measures to control mosquito vectors and infections transmitted by mosquitoes by increasing people's awareness of the mode of disease transmission and information on how to protect themselves from the mosquitoes, keeping the environment clean, using personal protection, sleeping under bed nets, covering water containers, getting rid of stagnant water, etc. The Sudanese government also provides people with insecticide-treated mosquito nets. During and after autumn, pesticides are applied to control mosquitoes. Sentinel surveillance of the incidence and seroprevalence of dengue at qualifying health facilities combined with measurement of vector indices in the catchment area will be helpful to examine the effectiveness of the control programme, to signal epidemiological trends and to monitor the burden of dengue in the country. This is the first study in Sudan that used dengue neutralisation assays to determine the breadth of the DENVspecific antibody response. Sera from the subjects from Port Sudan and several of the sera from Kassala and El Obeid broadly neutralised all four DENV serotypes indicating repeated infections with several dengue viruses. These individuals may be protected from further symptomatic DENV infection [30] . The remaining subjects showed cross-reactive nAb responses mainly against two or three viral serotypes. These individuals may be susceptible to secondary or tertiary DENV infection with another serotype. The nAb responses were broadly distributed against all four serotypes. In El Obeid, nAb against DENV-2 were slightly less frequent indicating that this virus subtype is less prevalent. Most sera neutralised DENV-4 although this serotype has not yet been reported from Sudan [3] . The presence of neutralising antibodies against DENV-4 may either indicate that the participants had been infected with DENV-4 or that infection with other DENV serotypes stimulated the production of antibodies that cross-neutralised DENV-4.
The study has the following limitations: The purpose of the study was to determine the seroprevalence of dengue in the general population. However, the sera were from patients with fever visiting outpatient clinics. We did not elicit socio-economic data from the patients. Since infectious diseases are more frequent in poor socio-economic environments, selection of the sample depending on fever may have resulted in a higher percentage of sera from poor individuals. Recent evidence from other countries indicates that lower socio-economic status is associated with a higher dengue incidence rate. In Noum ea, New Caledonia, the dengue incidence rate was 1.3-1.4 times higher in neighbourhoods with lower socio-economic status [31] . Similar data are not yet available from Sudan, but in Port Sudan the entomological indices for A. aegypti were higher in low and middle-class neighbourhoods suggesting that exposure to mosquitoes is higher in these parts of the city [6] . If a selection bias towards patients from lower socio-economic background occurred, the dengue IgG seroprevalence in the study areas is slightly lower than in the samples.
The reasons for selecting patients rather than random community samples were that the sera were originally obtained for a dengue incidence study and at the time of planning it was considered to be difficult to get blood samples from healthy people. Blood sampling from patients with fever probably resulted in a higher percentage of samples from acute dengue compared with the general population. To correct the sampling to a population that more closely reflected the general population, sera that were IgG-and IgM-positive, were excluded. The remaining serum sample was considered unbiased by fever in terms of a previous DENV infection. Two small groups of patients that were not identified by the laboratory tests were neglected: Firstly, a fraction of the IgG-and IgM-positive samples that were excluded could be from individuals with acute secondary infection rather than from late acute primary infection. In a recent study, the fraction of IgM-positive sera among presumed secondary dengue was less than 10% [24] . Secondly, since dengue IgM can last for several months in the serum, we could not differentiate between acute dengue fever and fever for other reasons in a patient who was infected a few weeks to months ago. Sera from these groups of individuals would have slightly increased the seroprevalence rate.
Another limitation of the study with respect to generalising the results is that in two of the three states the specimens were obtained at single study sites. The states cover areas of 218 000 (Red Sea) 36 000 (Kassala), and 222 000 (North Kordofan) square kilometres and are inhabited by 1.4, 1.8 and 3 million people, respectively. The sampling method does not allow extrapolation of the data to populations outside the towns. As DENV infections spread more rapidly in the cities, the seroprevalence in rural areas may be lower than in towns. Similarly, the places of residence of the participants were not documented. This may have led to a sampling bias in El Obeid, a city housing hundreds of displaced persons.
All things considered, the study shows that a large fraction of the people in Port Sudan, Kassala state and El Obeid has been infected with dengue virus. In Port Sudan, the seroprevalence indicates almost universal exposure and the high antibody level suggests recent infection. Broad cross-neutralisation indicates infection with several dengue virus serotypes in many participants. Our results highlight the need to make healthcare workers and the population aware of dengue as a reason for febrile illness, emphasise the importance of a dengue surveillance system in Sudan and suggest that capacity be built for laboratory diagnosis of severe dengue cases.
